Several peptides were isolated from tryptic digests of insoluble calf aorta matrix by chromatography. Reductive pyridylethylation of a tryptic 15 kDa pool released fragments deriving from the C-terminus of type III collagen. A 50-residue peptide T C (III) was shown by sequence analysis to be the C-terminal peptide from the α1(III)-chain, containing a helical and nonhelical region of equal sizes. The peptide was further digested with collagenase to give Col C (III), comprising the complete Cterminal non-helical region of α1(III) including a hydroxylysine in position 16 C . The peptide T C (III)iT N (III) was isolated, demonstrating covalent cross-linking between the C-terminal non-helical region of one type III molecule and the N-terminal helical cross-linking region of another. Its digestion with cy-
INTRODUCTION
The complete primary structure of human [2, 3] and bovine [4] [5] [6] [7] [8] [9] type III collagen is known on the basis of the sequence analysis of either cDNA species from type III procollagen or α1(III)-derived peptides. The amino acid sequence of bovine α1(III), forming the helical domain of the type III molecule, contains the N-and C-terminal helical cross-linking sites -Gly-Met-Hyl-GlyHis-Arg-Gly-Phe (residues 94-101) and Gly-Ile-Hyl-Gly-HisArg-Gly-Phe-(residues 937-944), which are identical with the corresponding sites of the α1(I)-chain (residues 85-92 and 925-932) [10] . These regions, located in α1(III)CB7 and α1(III)CB9B, have been shown to be involved in cross-linking [11] . The telopeptides of bovine type III collagen, deriving from the N-and C-termini, have also been sequenced [12] [13] [14] and shown to contain one Lys\Hyl residue. The involvement of the N-terminal non-helical region in cross-link formation was demonstrated by sequence analysis of the trifunctional cross-linked peptide [Col N (III)] # iT N (III) isolated from human leiomyoma [1, 15] .
So far the occurrence of lysine-derived cross-links from the Cterminal non-helical domain of the α1(III)-chain has not been described. Here I present a cross-link analysis of this region for bovine aorta type III collagen.
METHODS Materials
Bio-Gel P-100 (100-200 mesh), Bio-Gel P-2 (200-400 mesh), BioGel A-1.5m (200-400 mesh) and AG 50W-X4 analytical grade cation-exchange resin (200-400 mesh) were from Bio-Rad (Richmond, CA, U.S.A.) ; Sephadex G-50(s) (200-400 mesh) was from Pharmacia (Uppsala, Sweden), and phosphocellulose P11
Abbreviations used : DHLNL, dihydroxylysinonorleucine ; HHL, histidinohydroxylysinonorleucine ; HLNL, hydroxylysinonorleucine ; TFA, trifluoroacetic acid. Nomenclature : T C (III)iT N (III) is a cross-linked peptide containing two polypeptide chains derived from α1(III) of type III collagen. T C (III) is the trypsin-derived peptide containing the C-terminal non-helical region of type III collagen. T N (III) is the trypsin-derived peptide containing the helical Nterminal cross-linking region of type III collagen. When T C (III)iT N (III) is treated with collagenase it becomes Col C (III)iT N (III), as the T N (III) component remains unaltered ; treated with cyanogen bromide it becomes T C (III)iGlyHisArg, as the T N (III) component contains two methionine residues. For the nomenclature of the cross-linked peptide [Col N (III)] 2 iT C (III) see [1] .
anogen bromide yielded the small fragments α1(III)CB3B* and α1(III)CB3C, confirming T N (III) as an N-terminal helical crosslink site. Sequence analysis of both T C (III)iT N (III) and its collagenase-derived cross-linked peptide Col C (III)iT N (III) established the 4D-staggered alignment of adjacent collagen III molecules. The cross-link structure of both peptides was mainly dihydroxylysinonorleucine with a small amount of hydroxylysinonorleucine, indicating that the lysine residues involved in formation of the cross-links are both hydroxylated. No pyridinoline or histidinohydroxylysinonorleucine cross-links were found within the non-reduced C-telopeptide region of type III collagen. . HPLCgrade reagents such as trifluoroacetic acid (TFA), heptafluorobutyric acid and isopropanol were from Fluka (Buchs, Switzerland), and acetonitrile and water were from Baker (Deventer, Holland). Reagents for amino acid analysis were from Pierce Co. (Rockford, IL, U.S.A.). All sequencer chemicals were from Applied Biosystems (Forster City, CA, U.S.A.). Calf aortas were delivered fresh from animals at slaughter.
Digestion of matrix and peptides
An insoluble matrix of calf aorta was prepared as outlined previously [1] . Approx. 77 g of matrix was obtained from 500 g of wet tissue. Digestion of the insoluble matrix with trypsin and peptides with bacterial collagenase was performed as described previously [1] . Cyanogen bromide cleavage of T C (III)iT N (III) followed the procedure of Bornstein et al. [16] .
Chromatographic separations
The 15 and 20 kDa fractions were fractionated by gel filtration on Bio-Gel P-100. Separation of the 20 kDa fraction from highmolecular-mass proteins was achieved by rechromatography on Bio-Gel Agarose A-1.5m. The pyridylethylated peptides and all collageneous digests were chromatographed on Sephadex G-50(s). The peptides T C (III) and T C (III)iT N (III) were finally purified by ion-exchange chromatography on phosphocellulose P 11. The small peptides α1(III)CB3B* and α1(III)CB3C were separated on Bio-Gel P-2. For conditions see the legends to the relevant figures. Reversed-phase HPLC of peptides was done with a Beckman HPLC system [17] . The peptides were applied to a high-pore reversed-phase HPLC column (Bio-Rad RP-318, 5 µm particle size, 300 A H pore size, 25 cmi4.6 mm), equilibrated in solution A (0.1 % TFA). Elution was performed at room temperature with a linear gradient [0-60 % B over 60 min] of solution B [0.1 % TFA in 70 % (v\v) isopropanol] at a flow rate of 1 ml\min.
Reduction and S-Pyridylethylation of proteins
Peptides containing disulphide bonds were reduced with 2-mercaptoethanol and the resulting thiol groups were alkylated by treatment with 4-vinylpyridine [18] . The standard amino acid S-β-(4-pyridylethyl)--cysteine was prepared by the method of Cavins and Friedman [19] .
Reduction with NaB 3 H 4
Sodium boro[$H]hydride (5 mCi ; specific radioactivity 100 mCi\mM), corresponding to 1.9 mg of NaBH % , was dissolved in 1.9 ml of 0.05 M sodium phosphate buffer, pH 8.0. A 100 µl portion (0.1 mg of NaBH % ) of the solution was added to 1 mg of T C (III)iT N (III). Reduction (1 h) was stopped by addition of one drop of 50 % acetic acid. The reduced peptide was desalted on AG 50W-X4 cation-exchange resin [17] and freezedried.
Amino acid analysis
Amino acid compositions of peptides were determined by automated amino acid analysis (Biotronik, model LC 6000 E) as outlined earlier [17] . Methionine was determined as homoserine. The dried hydrolysates of the peptides were treated with 0.1 M piperidine at 37 mC for 1 h, evaporated to dryness and immediately afterwards analysed with the standard programme.
Cysteine was determined as S-β-(4-pyridylethyl)--cysteine eluting behind arginine in the standard system. Identification of dihydroxylysinonorleucine (DHLNL) and hydroxylysinonorleucine (HLNL) was achieved by single-buffer elution with a 0.35 M sodium citrate buffer, pH 5.28, at 60 mC in combination with a split-stream device : one part of the effluent was submitted to ninhydrin detection, and the remainder was collected and monitored for $H in a scintillation counter (Packard) after mixing the single fractions (0.6 ml) with 9 ml of scintillation fluid (Instagel).
Amino acid sequencing
Amino acid sequences were determined with a Beckman liquidphase spinning-cup sequencer 890 C fitted with P6 Autoconverters (Sequamat, Watertown, MA, U.S.A.). A protein Quadrol program (0.5 M Quadrol coupling buffer) was used (model 890 C program 122974) and the anilinothiazolinone amino acids were converted into phenylthiohydantoins using methanolic HCl. The phenylthiohydantoin analysis was performed with reversed-phase HPLC [20] .
RESULTS
Approx. 7 % of the dry weight of calf aorta is type III collagen [21, 22] . Trypsin digestion of the denatured insoluble matrix, preserving telopeptides, released cross-linked peptides that were first fractionated on a Bio-Gel P-100 molecular sieve column ( Figure 1a) . The tryptic peptide [T C (III)] $ was expected to contain approx. 150 amino acids and so the 15 kDa fraction from the P-100 column was reduced, treated with vinylpyridine and separated on Sephadex G-50(s) (Figure 1b ). Pools 1-3 were purified by ion-exchange chromatography on phosphocellulose.
From its composition data, pool F3 was shown to contain peptide T C (III) S , comprising a helical and an incomplete nonhelical region of α1(III). The C-terminus of the peptide (Gly"!!'-Ala"!$() coincides with the pepsin cleavage point Ala"!$( ( Figure 2) . Pool F2 after chromatography on phosphocellulose proved to be heterogeneous. The different fractions represent the peptide T C (III) L ; sequence analysis yielded the 11-residue partial sequence Gly"!!'-Ser-Glu-Gly-Ser-Hyp-Gly-His-Hyp-Gly-Glu"!"' of α1(III) from calf aorta. T C (III) L (Gly"!!'-Tyr"!&#) contains the complete non-helical C-terminal region of α1(III) beyond the pepsin cleavage point of T C (III) S (Figure 2 ).
Pool F1 purified by ion-exchange chromatography was also resolved into several peaks, all containing the same cross-linked peptide T C (III) L iT N (III). Three sequences were found : Gly"!!'-Ser-Glu-Gly-Ser-Hyp-Gly-His-Hyp-Gly-Glu-Hyp-Gly-Pro"!"*, Gly)&-Pro-Ala-Gly-Met-Hyp-Gly-Phe-Hyp-Gly-Met*& and Gly('-Phe-Hyp-Gly-Pro-Hyp-Gly-Met)$. The first sequence corresponds to the 14 N-terminal residues of T C (III) and the second to the 11 N-terminal residues of T N (III) S (Figure 2 ). The (5) indicate the residues sequenced by automated Edman degradation. Partial sequences of T C (III) and T N (III), which were not sequenced, were taken from [9] and [4] respectively. Residue X within X-Gly-His-Arg stands for hydroxylysino-5-oxonorleucine.
formation of the 15-residue peptide (Gly)&-Arg**) is correlated with the occurrence of Lys)%. The third sequence also is T N (III), starting differently from T N (III) S at Gly('. The 24-residue peptide (Gly('-Arg**) containing Hyl)% is denoted by T N (III) L (Figure 2 ). The heterogeneity of T C (III)iT N (III) is caused by both peptide chains being present in different forms.
The identity of T N (III) S and the presence of a cross-link were confirmed by treating T C (III) L iT N (III) S with cyanogen bromide. After cleavage of T N (III) S , containing two methionine residues, the expected products α1(III)CB3C, α1(III)CB3B* and T C (III) L iXGlyHisArg were found (Figure 2 ). The five-residue peptide α1(III)CB3B*, i.e. α1(III)CB3B without Hyl\Lys, is formed by the occurrence of Lys)%.
Furthermore, conversion of T C (III) and T C (III)iT N (III) to the corresponding collagenase-treated fragments Col C (III) and Col C (III)iT N (III) made possible the identification of the complete C-telopeptide from bovine α1(III). The 26-residue sequence of Col C (III) consists of a non-helical domain apart from a triplet at the N-terminus (Figure 2) . The 11 N-terminal residues agree with residues 1027-1037 of α1(III) from calf skin [23] . The subsequent segment of 15 residues corresponds to residues 9 C -24 C of α1(III) from aortic smooth muscle cells, as deduced by nucleotide sequence analysis of a bovine α1(III)cDNA clone coding for the C-propeptide [14] . As shown by amino acid sequence analysis, Lys"' C is hydroxylated nearly completely. Sequence analysis of Col C (III)iT N (III) S very clearly documented the identity of the cross-linked regions and gave direct evidence for the involvement of Hyl"' C in cross-linking ( Figure 3) : Gly"!#(-Pro-Cys-Cys-Gly-Ala-Gly-Gly-Val-Ala-Ala-Ile[step 12]-Ala-Gly)&-Pro-Ala-Gly-Met-Hyp-Gly-Phe-Hyp-Gly-Met-Xaa*'-Gly-. No Lys\Hyl residue was present in position 96 (step 12), which is occupied by Lys\Hyl-derived cross-links.
Cross-link analysis of Col C (III)iT N (III) established the presence of dihydroxylysinonorleucine, which eluted as a ninhydrinpositive partly resolved double peak X, strongly labelled with tritium. Less than 10 % hydroxylysinonorleucine was present (Figure 4) . 
DISCUSSION
The analysis of collagen III cross-linking structures, containing the C-terminus of α1(III) as their basic component, is facilitated by the isolation of the C-telopeptide in its monomer non-crosslinked form. Its identification and quantitative determination contribute to the detection of cross-linking structures and can give an insight into their assembly. Reductive alkylation of the 15 kDa fraction from the trypsin-soluble aortic-collagen released peptide T C (III) L and digestion with collagenase yielded Col C (III) consisting almost completely of a non-helical domain, i.e. the collagen III C-telopeptide. The amino acid sequences of the C-telopeptides from collagen III and I, comprising approx. 25 residues, diverge considerably ( Figure 5) . A sequence divergence of approx. 77 % was found for man, calf and chicken. The C-telopeptide divergence between different species is much more extensive within collagen III than
Figure 3 Amino acid sequence analysis of Col C (III)iT N (III)
The first 13 steps are shown, together with an analysis of a standard 1 nmol of phenylthiohydantoin, to illustrate the presence of a double sequence. The peaks in the standard and sample are identified by the single-letter codes for amino acids. P* denotes 4-hydroxyproline, which elutes as two isomers ; Nl denotes norleucine, which was used as an internal standard ; PEC denotes pyridylethylcysteine.
within collagen I. A pairwise comparison between man\calf, man\chicken and calf\chicken yields values of 12 %, 4% and 8 % for collagen I, and 25 %, 62.5 % and 70.8 % for collagen III. The different collagen III C-telopeptides are of amphipathic nature, i.e. they have a polar group (Glu"& C , Lys"' C ) and two hydrophobic arms that can be thought to be stabilized by folding back on themselves. "H NMR studies of a synthetic type III Ctelopeptide indicated a β-turn within the polar region [27] , supporting the idea of a polar, more hydrophilic, region located on the molecule surface exposed to an aqueous environment and a non-polar region oriented to the interior of the fibril. The nonpolar segment of the C-telopeptide (Gly# C -Ala"% C and Ala"( CTyr#% C ) has the potential to interact with the helix T N (III) hydrophobic region that is N-terminal to residue 96 (Gly)&-Met*&), indicating its role in fibril assembly. The polar region of the type III C-telopeptide, containing the conserved partial sequence Glu-Lys-Ala ( Figure 5 ), is involved in cross-linking. The β-turn like fold of the C-telopeptide, putting Lys"' C into a conformation in which it could be a substrate for lysyl hydroxylase, should favour the synthesis of hydroxylysine, mainly found in Col C (III) of the vessel wall. The cross-link forming hydroxylysine occupies the same position (16 C ) within both Col C (III) and Col C (I), as shown for man, calf and chicken. Identical crosslinking domains within the non-helical as well as the helical regions of collagen III and I might allow formation of copolymers between both types of collagen. It is remarkable that the Col C (III)
Figure 4 Cross-link analysis of T C (III)iT N (III)
The acid hydrolysates of the reduced cross-linked peptide (A, B) and reduced bone tissue (C) for reference are compared by amino acid analysis. Cross-linking within T C (III)iT N (III) is dominated by dehydrodihydroxylysinonorleucine. The qualitative and quantitative pattern of the bivalent cross-links (90 % dehydro-DHLNL, 10 % dehydro-HLNL) agrees with that found in type III collagen of native bovine amnion tissue [28] . The dimer cross-
Figure 5 Amino acid sequences of C-telopeptides from α1(I) and α1(III)
Sequences of calf and chicken are shown only when they differ from the human. Symbols : , deletions in the chicken gene ; , amino acids absent from the human but present in the chicken chain. The C-telopeptide sequences of α1(I) were taken from [24] and those from α1(III) for man and chicken from [25] and [26] . The collagen III telopeptide sequence of calf was obtained by amino acid sequence analysis of Col C (III).
links are formed between the Hyl\Lys residues 16 C of Col C (III) and 96 of T N (III), taking into account the stereochemistry of the lysine residues, the chemical nature of the cross-links and the absence of a phenylthiohydantoin derivative of Hyl\Lys at the 16 C position. Another bivalent cross-link is assumed to be present in type III collagen, connecting two N-telopeptides of two different type III molecules and giving evidence for a registered alignment of type III molecules [1] (Figure 6c ).
The trifunctional cross-link pyridinoline has not been found in the 12 kDa fraction assumed to contain
. This finding is unexpected in view of the dominant presence of DHLNL in Col C (III)iT N (III), which is thought to be the precursor of pyridinoline [29] . The deficiency of pyridinoline and simultaneously high levels of DHLNL seem to be typical of immature tissues such as a 3-month-old calf aorta and can be explained by the occurrence of DHLNL as an acid-labile Schiff base. It is suggested that during maturation of cross-links, the Schiff base is rearranged into the ketoamine hydroxylysino-5-oxonorleucine (Hyl 96 -Hyl ald,"'C ) reacting with a telopeptide hydroxyallysine of a third α1(III)-chain (Hyl ald,"'C ) or a vicinal ketoamine to form pyridinoline. Formation of pyridinoline is basically possible within collagen III, as shown for the collagen III N-telopeptide region by isolation of the trimeric cross-linked peptide [T N (III)] # iT C (III) of calf aorta and human leiomyoma (W. Henkel, unpublished work) (Figure 6c ). The pathway of pyridinoline described is consistent with the packing mode of collagen III molecules (see below) and also the collagen I molecules of tendon [30] . Formation of pyridinoline should also proceed in collagen fibrils of skin and blood vessels tilted by about 18 m with respect to the fibril axis, taking into account the potential of pyridinoline to cross-link either two or three molecules [17, 31] . The occurrence of a pyridinoline linking three different molecules is inconsistent with the packing mode of skin collagen I molecules [32, 33] . The small intermolecular displacement of neighbouring molecules within a layer precludes a vicinal arrangement of the two telopeptide hydroxyallysine residues located on different molecules. The packing mode is, however, consistent with a pyridinoline linking two molecules. Then the two telopeptide hydroxyallysine residues involved, both located on the same molecule, would be adjacent to one another and allow formation of pyridinoline. Indeed, the twisted collagen I fibrils of aortic tissue have been shown to contain pyridinoline [17] . There is no correlation between the occurrence of pyridinoline and Dperiodicity within collagen fibrils. Pyridinoline has been found in tendon fibrils [34] with an axial D period of 67 nm and in collagen fibrils of aorta [17] or mineralized bone [35] with a decreased axial D period of 65 nm.
The absence of the trifunctional cross-link histidinohydroxylysinonorleucine (HHL) in the 12 kDa fraction might indicate that the C-telopeptide of collagen III cannot form any HHL, in contrast with the corresponding region of collagen I [32] . Formation of HHL in collagen III, equivalent to that in collagen I [36] , would require an α1(III)His"!" residue and the bivalent cross-link dehydro-HLNL connecting α1(III)Lys"' C and α1(III)Hyl*'. Synthesis of HHL cannot be realized in collagen III because dehydro-HLNL occurs only in small amounts and α1(III)His"!" is not present. Formation of HHL, involving His") C , as imaginable for type I collagen, must also be excluded, because Col C (III) does not contain any histidine ( Figure 5) . The failure to detect HHL in collagen III might be a direct consequence of the collagen III packing mode.
A first hint of the supramolecular assembly of type III molecules is the occurrence of [T C (III)iT N (III)] # iT C (III) (Figure 6b) . The dimer, consisting of two 4D-staggered molecules, obviously contains at least two Hyl\Lys-derived cross-links arranged parallel to the disulphide bonds. Furthermore, several dimers can be thought of as being cross-linked by 0D-staggered disulphide bonds, considering their intermolecular function [37] . Finally, bearing in mind the results of the collagen III cross-link analysis, a tetrameric structure is proposed, as represented in Figure 6 (c). Two sheets of in-register molecules, displaced against each other by 4D, are fixed in this arrangement by three strands of intermolecular bonds organized in a parallel manner. The disulphide bonds distinctive of type III collagen, present in duplicate at the C-terminal end of the triple helix, force the helical regions of collagen III molecules into a ' strict 0D stagger ' arrangement. This alignment is consolidated by lysine-derived bivalent cross-links (Lys) N -Lys) N ), connecting the N-telopeptides of different type III molecules. The 4D-staggered cross-links, deriving from either the N-telopeptide (Hyl) N -Hyl) N -Hyl*$*) or the C-telopeptide (Hyl"' C -Hyl*') are believed to stabilize the potential for a strict 0D-staggered alignment of type III molecules within a layer. The organization of a collagen III filament, on the basis of the tetramer structure, is represented schematically in Figure 6 (d). The proposed fibril structure is consistent with the configuration of pyridinoline, but incompatible with formation of HHL. The assembly of molecules has the implication that a His"!" residue of α1(III), essential for the formation of HHL, would have no function. This might be the reason why the histidine residue did not arise during evolution.
The packing mode of collagen III described in some respects is related to that of collagen I tendon. The in-register alignment of neighbouring molecules within layers [30] and the absence of HHL but the presence of pyridinoline could account for collagen III fibrils whose molecules are oriented along the fibril axis inducing a D-periodicity of 67 nm during the process of selfassembly. It would be of great interest to establish a model of electrostatic interactions between collagen III molecules, as has been done for collagen I molecules [33] , and to ask whether there is a causal relation between the maximum stabilization of type III molecules and their orientation relative to the fibril axis. The possibility cannot be excluded that in a later stage of fibrillogenesis the type III molecules are reoriented by the presence of other matrix molecules such as type I collagen. So far there are no experimental results on the orientation and D-periodicity of type III fibrils in a tissue.
The considerations on the collagen III packing mode could shed light on formation of collagen fibrils in the vessel wall. Collagen fibrils of aorta with a tilting angle of about 17 m, a shortened axial periodicity of 65 nm and small uniform diameters of about 50 nm [38] indicate the packing motif of collagen I skin [31] . The experimental results are explained by a packing mode of type I molecules which, different from that of collagen III, is distinguished by a ' near-register ' that is a small intermolecular offset of neighbouring molecules within a layer and a tilting of the molecules against the fibril axis by about 16 m [32] . This arrangement of molecules was computed to be the most stable [33] and is consistent with the configuration of HHL [32, 33] , which is suggested to occur in collagen I of the vessel wall. Furthermore the twisted fibrils of the aorta were shown to contain collagen III, as demonstrated by studies with monoclonal antibodies [39] . Finally there is experimental evidence that collagen III could regulate the diameter of collagen I fibrils [40] .
